The Global Genetic Testing Market
13 abril, 2023
The global genetic testing market has been exponentially gaining widespread attention since the outbreak of the Covid-19 pandemic, noted DNALabs Canada Inc. According to a
The global genetic testing market has been exponentially gaining widespread attention since the outbreak of the Covid-19 pandemic, noted DNALabs Canada Inc. According to a
Johnson & Johnson posted a 6.5% year-over-year increase in sales of its Stelara (ustekinumab) treatment for pediatric patients with juvenile psoriatic arthritis in 2022, to
Bristol-Myers Squibb Company obtained approvals of 18 new drugs and additional drug indications and formulations in 2022. These drugs are currently marketed in the company’s
Antibodies carry 500 million years of immune system evolution, refers the company OmniAb, who highlights the following about the therapeutics market. In 2021, approved antibody-based
China has a large patient base with significant unmet clinical needs, which has promoted the rapid development of the pharmaceutical market in recent years. Imports
AstraZeneca detailed the sales of its main cancer drugs in 2021, when they totaled 13,048 million dollars. It is a British-Swedish multinational pharmaceutical and biotechnology
The pharmaceutical company Novartis will invest 50 million dollars in clinical research in Mexico in the next triennium. All drug candidates undergo proof-of-concept trials to
AstraZeneca reported that it will invest $ 360 million in a new drug plant in Ireland. The company will establish a next-generation active pharmaceutical ingredient
AstraZeneca operates its main tablet and capsule formulation sites in the United Kingdom, Sweden, China, Puerto Rico and the United States. In addition, the company
The global genetic testing market has been exponentially gaining widespread attention since the outbreak of the Covid-19 pandemic, noted DNALabs Canada Inc. According to a
Johnson & Johnson posted a 6.5% year-over-year increase in sales of its Stelara (ustekinumab) treatment for pediatric patients with juvenile psoriatic arthritis in 2022, to
Bristol-Myers Squibb Company obtained approvals of 18 new drugs and additional drug indications and formulations in 2022. These drugs are currently marketed in the company’s
Antibodies carry 500 million years of immune system evolution, refers the company OmniAb, who highlights the following about the therapeutics market. In 2021, approved antibody-based
China has a large patient base with significant unmet clinical needs, which has promoted the rapid development of the pharmaceutical market in recent years. Imports
AstraZeneca detailed the sales of its main cancer drugs in 2021, when they totaled 13,048 million dollars. It is a British-Swedish multinational pharmaceutical and biotechnology
The pharmaceutical company Novartis will invest 50 million dollars in clinical research in Mexico in the next triennium. All drug candidates undergo proof-of-concept trials to
AstraZeneca reported that it will invest $ 360 million in a new drug plant in Ireland. The company will establish a next-generation active pharmaceutical ingredient
AstraZeneca operates its main tablet and capsule formulation sites in the United Kingdom, Sweden, China, Puerto Rico and the United States. In addition, the company
Redacción: 7224059128
info@opportimes.com